Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Shingles in the COVID-19 Era: Risk Factors and Complications—Audio Recap

What puts your older patients at risk for shingles? What is their risk of developing postherpetic neuralgia? Listen to expert insights from Tracy Zivin-Tutela, MD, on risk factors and complications of shingles.
Tracy Zivin-Tutela, MD
Released: September 24, 2021

In this episode, Tracy Zivin-Tutela, MD, discusses factors that put your patients at risk for shingles and its complications.

Using a case study and the latest data, this podcast covers topics such as:

  • Pathophysiology and epidemiology
  • Disease burden and potential complications in older patients, including postherpetic neuralgia
  • Risk factors, including age, immunosenescence, chronic diseases, unvaccinated status

Information on this Educational Activity


Tracy Zivin-Tutela, MD

Attending Physician 
Division of Infectious Diseases
Department of Medicine
Los Alamitos Medical Center, Fountain Valley Regional Hospital
New Brunswick, California

Tracy Zivin-Tutela, MD, has no relevant conflicts of interest to disclose.

Program Medium

This program has been made available online.


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by

Related Content

Dr Roger Paredes on treating mild cases of COVID-19 with antiviral agents to reduce symptom duration, from Clinical Care Options (CCO)

Roger Paredes, MD, PhD Released: December 6, 2022

La Dra. Cristina Mussini analiza si los antivirales contra la COVID-19 están resultando beneficiosos para la prevención y/o el tratamiento de la COVID persistente, de Clinical Care Options (CCO)

Cristina Mussini, MD Released: December 5, 2022

La dott.ssa Cristina Mussini discute se gli antivirali contro la COVID-19 si stiano dimostrando utili nella prevenzione e/o nel trattamento della Long COVID, da Clinical Care Options (CCO)

Cristina Mussini, MD Released: December 5, 2022

Cristina Mussini, MD Released: December 5, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings